EUCTR2013-004910-16-FR进行中（未招募）不适用
Therapeutic multicentric phase II trial evaluating the efficacy of omalizumab (Xolair ®) in idiopathic refractory severe solar urticaria
Centre Hospitalier régional Universitaire de Besançon0 个研究点开始时间: 2015年6月22日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A multicenter phase II clinical trial assessing the efficacy of the combination of lapatinib and capecitabine in patients with non pretreated brain metastasis from HER2 positive breast cancer. - LANDSCAPEEUCTR2008-001084-10-FRFNCLCC
进行中（未招募）
1 期
Encorafenib and binimetinib before local treatment in patients with BRAF mutated melanoma with metastasis to the brain.EUCTR2018-002530-20-ESGrupo Español Multidisciplinar de Melanoma63
进行中（未招募）
不适用
A phase II, multicentre, clinical study evaluating the safety and efficacy of Treosulfan-based conditioning of allogenic transplantation of haemopoietic stem-cells in patients affected by Thalassemia Major - NDEUCTR2005-005913-40-ITOSPEDALE POLICLINICO S. MATTEO10
已完成
2 期
The safety of Cpn10 in patients with multiple sclerosisNeurological - Multiple sclerosisMultiple SclerosisACTRN12606000037505CBio Limited50
未知
2 期
A Phase II, Multicenter, Clinical Trial to Evaluate The Efficacy and Safety of Bevacizumab in Recurrent Malignant GliomaMalignant gliomaJPRN-jRCT2080220811Chugai Pharmaceutical Co., Ltd.31